Terms: = Ovarian cancer AND LDH AND Prognosis
20 results:
1. High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.
Brzezinska B; Mysona DP; Richardson KP; Rungruang B; Hopkins D; Bearden G; Higgins R; Johnson M; Satter KB; McIndoe R; Ghamande S; Purohit S
Gynecol Oncol; 2023 Dec; 179():1-8. PubMed ID: 37862814
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of the clinical characteristics and prognosis between clear cell carcinomas and high-grade serous ovarian carcinomas.
Dong S; Yu F; Liu Y; Yu X; Sun X; Wang W; Wang Y
Ginekol Pol; 2023; 94(10):792-798. PubMed ID: 36477777
[TBL] [Abstract] [Full Text] [Related]
3. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
[TBL] [Abstract] [Full Text] [Related]
4. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
5. Lower expression of NINJ1 (Ninjurin 1), a mediator of plasma membrane rupture, is associated with advanced disease and worse prognosis in serous ovarian cancer.
Berkel C; Cacan E
Immunol Res; 2023 Feb; 71(1):15-28. PubMed ID: 36184655
[TBL] [Abstract] [Full Text] [Related]
6. Gynecologic cancer in pregnancy.
Korenaga TK; Tewari KS
Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
[TBL] [Abstract] [Full Text] [Related]
7. Primary appendiceal mucinous neoplasm: Gynecological manifestations, management, and prognosis.
Zhang W; Tan C; Xu M; Wu X
Gynecol Oncol; 2020 Feb; 156(2):357-362. PubMed ID: 31839341
[TBL] [Abstract] [Full Text] [Related]
8. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C
Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505
[TBL] [Abstract] [Full Text] [Related]
9. Peritoneal Nodules in a Pediatric Patient with Benign Teratoma. A Case Report and Review of Literature.
Badru F; Saxena S; Munoz-Abraham AS; Guzman MA; Bansal S; Chatoorgoon K
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):632-636. PubMed ID: 29990549
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis of proliferative lesions of haematopoietic and lymphoid tissue in the female productive tract].
Chen DB; Zhang H; Zhang YH; Wang Y; Song QJ; Yang SM; Cui H; Zhao Y; Fang XZ; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):263-269. PubMed ID: 29747272
[No Abstract] [Full Text] [Related]
11. Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis.
Lee SY; Jeon HM; Kim CH; Ju MK; Bae HS; Park HG; Lim SC; Han SI; Kang HS
Mol Cancer; 2011 Sep; 10():113. PubMed ID: 21917150
[TBL] [Abstract] [Full Text] [Related]
12. Congenital juvenile granulosa cell tumor of the testis in newborns.
Zugor V; Labanaris AP; Witt J; Seidler A; Weingärtner K; Schott GE
Anticancer Res; 2010 May; 30(5):1731-4. PubMed ID: 20592370
[TBL] [Abstract] [Full Text] [Related]
13. [Expression of VEGF and its significance in primary diffuse large B-cell lymphoma of the female genital system].
Tang QL; Jiang XF; Yang KZ; Li HG; Liu WP; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):48-51. PubMed ID: 19292043
[TBL] [Abstract] [Full Text] [Related]
14. Serum and tissue ldh levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.
Yüce K; Baykal C; Genç C; Al A; Ayhan A
Eur J Gynaecol Oncol; 2001; 22(3):228-32. PubMed ID: 11501779
[TBL] [Abstract] [Full Text] [Related]
16. Serum lactic dehydrogenase and primary carcinoma of the ovary.
Younis JS; Zeevi D; Hadani PE; Anteby SO
Gynecol Obstet Invest; 1989; 28(1):47-50. PubMed ID: 2777134
[TBL] [Abstract] [Full Text] [Related]
17. Randomized trial of the addition of cis-platin (DDP) and/or BCG to cyclophosphamide (CTX) chemotherapy for ovarian carcinoma.
Wilbur DW; Rentschler RE; Wagner RJ; Keeney ED; King A; Hilliard DA
J Surg Oncol; 1987 Mar; 34(3):165-9. PubMed ID: 3546949
[TBL] [Abstract] [Full Text] [Related]
18. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
Kawai M; Yamashita H; Hayashi T; Kamiya N; Kakihara M; Arii Y
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):402-10. PubMed ID: 3457877
[TBL] [Abstract] [Full Text] [Related]
19. [Studies on immunosuppressive acidic protein (IAP) in ovarian tumors].
Miyoshi T; Nishimura H; Hamai J; Yamada T; Tomoo Y; Kobayashi H; Yakushiji M; Kato T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):923-9. PubMed ID: 2991397
[TBL] [Abstract] [Full Text] [Related]
20. Serum lactic dehydrogenase: a tumor marker of ovarian dysgerminoma in a female pseudohermaphrodite.
Pode D; Kopolovic S; Gimmon Z
Gynecol Oncol; 1984 Sep; 19(1):110-3. PubMed ID: 6469085
[TBL] [Abstract] [Full Text] [Related]
